Corrigendum: T-cell activation is an immune correlate of risk in BCG vaccinated infants.

Corrigendum: T-cell activation is an immune correlate of risk in BCG vaccinated infants.

Bibliographic Details
Main Authors:	Fletcher, H, Snowden, M, Landry, B, Rida, W, Satti, I, Harris, S, Matsumiya, M, Tanner, R, O'Shea, M, Dheenadhayalan, V, Bogardus, L, Stockdale, L, Marsay, L, Chomka, A, Harrington-Kandt, R, Manjaly Thomas, Z, Naranbhai, V, Stylianou, E, Darboe, F, Penn-Nicholson, A, Nemes, E, Hatheril, M, Hussey, G, Mahomed, H, Tameris, M, McClain, J, Evans, T, Hanekom, W, Scriba, T, McShane, H
Format:	Journal article
Language:	English
Published:	Nature Publishing Group 2016

Similar Items

T-cell activation is an immune correlate of risk in BCG vaccinated infants
by: Fletcher, H, et al.
Published: (2016)

Cytomegalovirus infection is a risk factor for TB disease in infants
by: Müller, J, et al.
Published: (2019)

T-cell activation is an immune correlate of risk in BCG vaccinated infants
by: Helen A. Fletcher, et al.
Published: (2016-04-01)

Correction: Corrigendum: T-cell activation is an immune correlate of risk in BCG vaccinated infants
by: Helen A. Fletcher, et al.
Published: (2016-05-01)

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial.
by: Tameris, MD, et al.
Published: (2013)

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: A randomised, placebo-controlled phase 2b trial
by: Tameris, MD, et al.
Published: (2013)

Process of Assay Selection and Optimization for the Study of Case and Control Samples from a Phase IIb Efficacy Trial of a Candidate Tuberculosis Vaccine, MVA85A
by: Harris, SA, et al.
Published: (2014)

Inflammatory and myeloid-associated gene expression before and one day after infant vaccination with MVA85A correlates with induction of a T cell response
by: Matsumiya, M, et al.
Published: (2014)

Inflammatory and myeloid-associated gene expression before and one day after infant vaccination with MVA85A correlates with induction of a T cell response.
by: Matsumiya, M, et al.
Published: (2014)

Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study
by: Andrews, J, et al.
Published: (2017)

Lessons learnt from the first efficacy trial of a new infant tuberculosis vaccine since BCG.
by: Tameris, M, et al.
Published: (2013)

Lessons learnt from the first efficacy trial of a new infant tuberculosis vaccine since BCG
by: Tameris, M, et al.
Published: (2013)

The role of clinical symptoms in the diagnosis of intrathoracic tuberculosis in young children
by: Mcshane, H, et al.
Published: (2015)

Comparison of haematology and biochemistry parameters in healthy South African infants with laboratory reference intervals.
by: Schmidt, B, et al.
Published: (2017)

Publishing vaccine trial results – Does there have to be a delay?
by: McShane, H, et al.
Published: (2014)

Gene expression and cytokine profile correlate with mycobacterial growth in a human BCG challenge model
by: Matsumiya, M, et al.
Published: (2014)

The candidate TB vaccine, MVA85A, induces highly durable Th1 responses
by: Tameris, M, et al.
Published: (2014)

Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa.
by: Hawkridge, T, et al.
Published: (2008)

Risk of disease after isoniazid preventive therapy for mycobacterium tuberculosis exposure in young HIV uninfected children
by: Mcshane, H, et al.
Published: (2015)

The candidate TB vaccine, MVA85A, induces highly durable Th1 responses.
by: Tameris, M, et al.
Published: (2014)

Impact of isoniazid preventive therapy on the evaluation of long-term effectiveness of infant MVA85A vaccination
by: Bunyasi, E, et al.
Published: (2017)

Heterologous vaccination against human tuberculosis modulates antigen-specific CD4+ T-cell function.
by: Dintwe, O, et al.
Published: (2013)

Improvement of BCG protective efficacy with a novel chimpanzee adenovirus and a modified vaccinia Ankara virus both expressing Ag85A
by: Stylianou, E, et al.
Published: (2015)

Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb)
by: Marsay, L, et al.
Published: (2013)

Isolation of non-tuberculous mycobacteria in children investigated for pulmonary tuberculosis.
by: Mark Hatherill, et al.
Published: (2006-12-01)

Optimisation of a human BCG challenge model
by: Wilkie, M, et al.
Published: (2015)

Optimization of a human bacille Calmette-Guerin challenge model: a tool to evaluate antimycobacterial immunity
by: Minhinnick, A, et al.
Published: (2015)

Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells.
by: Scriba, T, et al.
Published: (2010)

The influence of haemoglobin and iron on in vitro mycobacterial growth inhibition assays
by: Tanner, R, et al.
Published: (2017)

Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb).
by: Marsay, L, et al.
Published: (2013)

Dose-finding study of the novel tuberculosis vaccine, MVA85A, in healthy BCG-vaccinated infants.
by: Scriba, T, et al.
Published: (2011)

Designing an adaptive phase II/III trial to evaluate efficacy, safety and immune correlates of new TB vaccines in young adults and adolescents.
by: Rustomjee, R, et al.
Published: (2013)

Designing an adaptive phase II/III trial to evaluate efficacy, safety and immune correlates of new TB vaccines in young adults and adolescents
by: Rustomjee, R, et al.
Published: (2013)

Critical Synthesis Package: Stanford Presenteeism Scale (SPS-6)
by: Elizabeth McClain
Published: (2013-10-01)

Critical Synthesis Package: Helpful Responses Questionnaire (HRQ)
by: Elizabeth McClain
Published: (2015-02-01)

A phase IIa trial of the new tuberculosis vaccine, MVA85A, in HIV- and/or Mycobacterium tuberculosis-infected adults.
by: Scriba, T, et al.
Published: (2012)

Hepcidin deficiency and iron deficiency do not alter tuberculosis susceptibility in a murine M. tb infection model
by: Harrington-Kandt, R, et al.
Published: (2018)

Likes, comments, and shares of marine organism imagery on Facebook
by: Craig R. McClain
Published: (2019-04-01)

Foreign investment in United States manufacturing and the theory of direct investment.
by: McClain, David Stanley
Published: (2005)

Continuing the promise: Recruiting and preparing Hmong-American educators for Central Wisconsin
by: Leslie McClain-Ruelle
Published: (2005-12-01)